Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joanne Sloan‐Lancaster
Observed names:
J SLOANLANCASTER,
J Sloan-Lancaster,
J. Sloan‐Lancaster,
JS Sloan‐Lancaster,
Joanne Sloan-Lancaster,
Joanne Sloan-Lancastert,
Joanne Sloan-lancaster,
Joanne Sloan-lancaster Phd
show all 8
Observed institutions:
National Institutes of Health,
Mayo Clinic,
Eli Lilly (United States),
Washington University in St. Louis,
NGM Biopharmaceuticals (United States),
Eunice Kennedy Shriver National Institute of Child Health and Human Development
show all 6
OpenAlex ID:
A5113669475
LAT
1998
·
Weiguo Zhang
, Joanne Sloan-Lancaster
, et al.
·
Cell
·
1,267
PDF
Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell Biology
1996
·
Joanne Sloan-Lancaster
, Paul M. Allen
·
Annual Review of Immunology
·
676
Partial T cell signaling: Altered phospho-? and lack of zap70 recruitment in APL-induced T cell anergy
1994
·
J SLOANLANCASTER
·
Cell
·
594
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
1993
·
Joanne Sloan-Lancaster
, Brian D. Evavold
, et al.
·
Nature
·
587
LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double‐blind, placebo‐controlled, proof‐of‐concept study
2010
·
M. C. Genovese
, F. Van den Bosch
, et al.
·
Arthritis & Rheumatism
·
451
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands
1993
·
Brian D. Evavold
, Joanne Sloan-Lancaster
, et al.
·
Immunology Today
·
410
Specific T cell recognition of minimally homologous peptides: Evidence for multiple endogenous Ligands
1995
·
Brian D. Evavold
, Joanne Sloan-Lancastert
, et al.
·
Immunity
·
206
PDF
Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes
2013
·
Joanne Sloan-Lancaster
, Eyas Abu-Raddad
, et al.
·
Diabetes Care
·
184
PDF
Th2 cell clonal anergy as a consequence of partial activation.
1994
·
J Sloan-Lancaster
, B D Evavold
, et al.
·
The Journal of Experimental Medicine
·
169
PDF
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides
1993
·
B D Evavold
, J Sloan-Lancaster
, et al.
·
The Journal of Immunology
·
165
Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype
1997
·
J Sloan-Lancaster
, T H Steinberg
, et al.
·
The Journal of Immunology
·
86
Selective activation of the calcium signaling pathway by altered peptide ligands.
1996
·
J Sloan-Lancaster
, T H Steinberg
, et al.
·
The Journal of Experimental Medicine
·
78
PDF
Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo‐Controlled Trial
2013
·
M. C. Genovese
, S. Bojin
, et al.
·
Arthritis & Rheumatism
·
69
Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand.
1994
·
B D Evavold
, J Sloan-Lancaster
, et al.
·
Proceedings of the National Academy of Sciences
·
68
ZAP-70 Association with T Cell Receptor ζ (TCRζ): Fluorescence Imaging of Dynamic Changes upon Cellular Stimulation
1998
·
Joanne Sloan-Lancaster
, John Presley
, et al.
·
The Journal of Cell Biology
·
66
Significance of T-cell stimulation by altered peptide ligands in T cell biology
1995
·
Joanne Sloan-Lancaster
, Paul M Allen
·
Current Opinion in Immunology
·
65
Regulation of ZAP-70 Intracellular Localization: Visualization with the Green Fluorescent Protein
1997
·
Joanne Sloan-Lancaster
, Weiguo Zhang
, et al.
·
The Journal of Experimental Medicine
·
47
PDF
LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase
2017
·
Joanne Sloan-Lancaster
, Eyas Raddad
, et al.
·
Journal of the Renin-Angiotensin-Aldosterone System
·
39
PDF
Differential Mechanisms of Plasminogen Activator Inhibitor-1 Gene Activation by Transforming Growth Factor-β and Tumor Necrosis Factor-α in Endothelial Cells
2001
·
Yan Chen
, Joanne Sloan-Lancaster
, et al.
·
Thrombosis and Haemostasis
·
39
Determination of the Mechanism of Action of Anti-FasL Antibody by Epitope Mapping and Homology Modeling
2009
·
Victor H. Obungu
, Valentina Gelfanova
, et al.
·
Biochemistry
·
25
Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations
2014
·
Sébastien Bihorel
, Jill Fiedler-Kelly
, et al.
·
The AAPS Journal
·
19
PDF
Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabetic Nephropathy
2018
·
Joanne Sloan‐Lancaster
, Eyas Raddad
, et al.
·
Clinical Pharmacology in Drug Development
·
7
Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor
2013
·
E Raddad
, MR Melhem
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
4
PDF
Signalling Events in the Anergy Induction of T Helper 1 Cells
2007
·
Joanne Sloan‐Lancaster
, Paul M. Allen
·
Novartis Foundation symposium
·
4
Targeting Calcium Release–activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation
2020
·
Jean Kwun
, Brian Ezekian
, et al.
·
Transplantation
·
3
Show more works
View as search
Works count:
32
Citation count:
5,330
H-index:
20
I10-index:
21
Year
Topic
Type
